News wire article from our research archive:

New York, Washington Inventors Develop Growth Blocking Agents

ALEXANDRIA, Va., Sept. 4 -- Edward V. Quadros of Brooklyn, N.Y., Sheldon P. Rothenberg of New York, and A. Charles Morgan, Jr. of Edmonds, Wash., have developed a monoclonal antibody.

According to the U.S. Patent & Trademark Office: "There is disclosed anti-receptor and growth blocking agents to the vitamin B.sub.12/transcobalamin II receptor and binding sites. The anti-receptor and growth blocking agents antagonize or modulate the vitamin B.sub.12/transcobalamin II receptor or binding sites, causing cellular depletion of vitamin B.sub.12, thus inhibiting cell division or causing apoptosis. Anti-receptor and growth blocking agents of the present invention include proteins (such as ...

Related newspaper, magazine, and journal articles:

See all results. Or, try our Advanced Search.

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 60 million articles! Access over 3,500 publications with a FREE trial!